Overview

Dashboard News

UBS maintains neutral rating for Siemens Healthineers with 53 Euro target

UBS has maintained a "Neutral" rating for Siemens Healthineers, setting a price target of €53. Analyst Graham Doyle noted the company's strengthened leadership in photon-counting computed tomography (PCCT) with an expanded product pipeline, allowing them to cater to diverse target groups and budgets.
boerse.de
Euro SIEMENS HEALTHINEERS CHE DEU Graham Doyle
TradFi, Market Report
15:14 02.12.2024

ubs maintains neutral rating for novo nordisk amid stagnant demand for wegovy

UBS has maintained a "Neutral" rating for Novo Nordisk, setting a target price of 1100 Danish kroner. Despite the reavailability of the weight loss drug Wegovy, analyst Jo Walton noted a lack of significant demand increase in the US market.
boerse.de
Danish Krone Novo Nordisk A/S DNK Jo Walton
TradFi, Market Report
15:13 02.12.2024

ubs maintains neutral rating for siemens healthineers with target price of 53 euros

UBS AG has maintained a "Neutral" rating for Siemens Healthineers, setting a target price of 53 euros. The company has expanded its photon-counting computed tomography (PCCT) pipeline from one to three devices, enhancing its market reach.As of 14:47, Siemens Healthineers shares rose by 1.0% to EUR 51.84, indicating a potential increase of 2.24% towards the target price. The stock has gained 0.4% over 2024, with the Q1 2025 balance sheet presentation scheduled for February 6, 2025.
finanzen.at
Euro SIEMENS HEALTHINEERS DEU Graham Doyle
TradFi, Market Report
15:04 02.12.2024

EQT Corporation maintains strong position as leading natural gas producer in America

EQT Corporation stands as America's top natural gas producer, with revenues primarily derived from the sale of natural gas (89.6%), predominantly in the Appalachian basins. Additional revenue comes from liquefied natural gas sales (8.5%) and oil sales (1.9%). UBS maintains a neutral stance on the stock.
Zonebourse
United States Dollar EQT Corporation USA
TradFi, Market Report
15:04 02.12.2024

ubs maintains neutral rating on eqt corporation amid strong natural gas sales

EQT Corporation, the leading American natural gas producer, has received a neutral rating from UBS. The company's sales breakdown reveals that 89.6% comes from natural gas, primarily from Appalachian operations, while liquefied natural gas accounts for 8.5% and oil for 1.9%.
MarketScreener
United States Dollar EQT Corporation USA
TradFi, Market Report
15:04 02.12.2024

ubs maintains neutral rating for siemens healthineers with target price of 53 euros

UBS has maintained a 'Neutral' rating for Siemens Healthineers, setting a target price of 53 euros. Analyst Graham Doyle noted the company's strengthened position in photon-counting computed tomography (PCCT) with an expanded pipeline of three devices, allowing it to cater to various target groups and budgets.
MarketScreener
Euro SIEMENS HEALTHINEERS DEU Graham Doyle
TradFi, Market Report
15:01 02.12.2024

DAX Hits Record High Amid Focus on US Labor Market Data

The DAX reached a record high of over 19,843 points, with investors shifting focus to the upcoming US non-farm payrolls report amid challenges in the French government. Economists anticipate strong job growth following a slump in October, influenced by recent hurricanes and strikes. Key US economic data, including the ISM manufacturing index and ADP employment figures, will also be closely monitored this week.
IG
United States Dollar Euro Boeing Co DEU FRA USA Michel Barnier Jerome Powell Show more
TradFi, Market Report
15:00 02.12.2024

novo nordisk focuses on diabetes and obesity treatments with global sales reach

Novo Nordisk A/S focuses on the design, manufacture, and marketing of pharmaceutical products, with 92.6% of sales from diabetes and obesity treatments and 7.4% from rare disease therapies, including hemophilia and hormonal disorders. Geographically, sales are distributed as follows: 54.9% in the United States, 21.9% in Europe-Middle East-Africa, 7.2% in China, 3.9% in North America, and 12.1% in other regions.
Zonebourse
United States Dollar Novo Nordisk A/S CHN USA DNK Show more
TradFi, Market Report
15:00 02.12.2024

ubs maintains neutral rating for novo nordisk with target price of 1100 kroner

UBS has maintained a 'Neutral' rating for Novo Nordisk, setting a target price of 1100 Danish crowns. Despite the reavailability of the weight loss drug Wegovy, analyst Jo Walton noted a lack of significant demand increase in the USA.
MarketScreener
United States Dollar Danish Krone Novo Nordisk A/S DNK Jo Walton
TradFi, Market Report
15:00 02.12.2024

CVS Health faces challenges but aims for recovery by 2025

CVS Health has faced significant challenges, with its stock down 25% year-to-date and over 40% from its peak in February 2022, primarily due to rising medical costs impacting profitability. Despite a solid revenue increase of 6.3% and record pharmacy sales, the company underestimated healthcare plan pricing for 2024, leading to disappointing earnings. However, a management shakeup and strategic changes signal a potential turnaround as CVS aims for stronger earnings by 2025.
Yahoo Finance
UnitedHealth Group Inc CVS Health Corp USA
Healthcare, Market Report
14:56 02.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Market Sentiment Analysis Cryptocurrency & Blockchain Regulations Inflation Rates & CPI Data Decentralized Finance (DeFi) Innovations Mergers & Acquisitions Banking Regulations Corporate Responsibility & ESG Hedge Funds & Private Equity Cryptocurrency Regulations Market Analysis and Predictions Anti-Money Laundering (AML) Regulations Tokenomics and Crypto Economics Banking & Investment Regulations Bond Market & Treasury Yields SEC & Financial Compliance Employment Reports
Countries:
USA CHE CHN IND GBR RUS SGP JPN CAN DEU KOR HKG FRA ITA SLV ARE IRL AUS SWE BRA
Companies:
Coinbase Global, Inc. Apple Inc. NVIDIA Corporation Solana USD BlackRock, Inc. MicroStrategy Inc JPMorgan Chase & Co. Ripples USD Novartis AG Tesla, Inc. Kraken Energy Corp. Ethereum USD The Goldman Sachs Group, Inc. Bank of America Corporation Credit Suisse Real Estate Fund Siat Bitwise Bitcoin ETF Capital One Financial Corporation Moderna, Inc. Grayscale Bitcoin Trust ETF UBS Group AG
Currencies:
United States Dollar Euro Swiss Franc Chinese Yuan British Pound Sterling Indian Rupee Japanese Yen Australian Dollar South Korean Won Russian Ruble Canadian Dollar Hong Kong Dollar Bahamian Dollar Malaysian Ringgit United Arab Emirates Dirham Swedish Krona Thai Baht
People:
Donald Trump Elon Musk Ali Martinez Peter Brandt Gary Gensler Joe Biden Paul Atkins Michael J. Saylor David O. Sacks Changpeng Zhao Justin Sun Scott Bessent Nate Geraci Paolo Ardoino Paul Grewal Stephanos Bibas Carl Runefelt Kubra Khan Shytoshi Kusama Charles Hoskinson

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings